Phenolic Derivatives Modulating Androgen Receptors

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current androgen receptor modulators are inadequate in effectively addressing hormone-dependent cancers and other androgen-related disorders, such as prostate cancer and breast cancer, due to limitations in modulating androgen receptor activity.

Innovation Solution

Development of novel phenolic derivatives with specific structural formulas that act as powerful androgen receptor modulators, capable of partial or total antagonist or agonist activities, which can be used to treat hormone-dependent cancers and androgen-related disorders.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current androgen receptor modulators are used, then treatment of androgen-related disorders is provided, but the modulators are inadequate in effectively addressing hormone-dependent cancers and other androgen-related disorders

Engineering Contradiction:
Improveeffectiveness of androgen receptor modulationVSAvoidrange of treatable conditions
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent modifies the chemical structure of androgen receptor modulators by changing parameters such as the introduction of fluorine atoms at specific positions (e.g., 7-fluoro, 6-fluoro), modification of the D-ring structure, and adjustment of substituent groups. These parameter changes in the molecular structure enhance the reliability of androgen receptor modulation while expanding the versatility to treat multiple conditions including prostate cancer, breast cancer, and other androgen-related disorders

Inventive Principle:
Principle #35Parameter changes

2Reliability

If novel phenolic derivatives with specific structural formulas are developed, then powerful androgen receptor modulator activity is achieved, but the complexity of compound structure increases

Engineering Contradiction:
Improveandrogen receptor modulator activityVSAvoidstructural complexity of phenolic derivatives
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the steroid molecule into distinct rings (A, B, C, D rings) and independently optimizes each segment. The A-ring contains the phenolic hydroxyl group, the B-ring contains the 6-fluoro substitution, the C-ring maintains the keto group, and the D-ring is modified with various substituents. This segmentation allows systematic development of analogs with improved activity while managing structural complexity through modular design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality modifications by introducing specific functional groups at precise locations in the molecule. For example, fluorine atoms are placed at specific positions (6-fluoro, 7-fluoro), hydroxyl groups are positioned at the A-ring (phenolic position), and various substituents are added to the D-ring. These localized modifications enhance androgen receptor modulator activity without requiring complete restructuring of the entire molecule

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS10202346B2Phenol derivatives and the pharmaceutical or cosmetic use thereof
Publication Date: 2019.02.12 GALDERMA RESEARCH & DEVELOPMENT SNC
  • US10202346B2 patent drawing
  • US10202346B2 patent drawing
  • US10202346B2 patent drawing

AI summary

The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I):or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.